Vitisin C
Latest Information Update: 24 Apr 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Nitric oxide synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Vascular disorders
Most Recent Events
- 09 Jun 2000 New profile
- 09 Jun 2000 Preclinical development for Vascular disorders in Japan (Unknown route)